SEI Medical PCL
SET:SEI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (3.1), the stock would be worth ฿2.91 (49% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.1 | ฿1.95 |
0%
|
| 3-Year Average | 3.1 | ฿2.91 |
+49%
|
| 5-Year Average | 3.1 | ฿2.91 |
+49%
|
| Industry Average | 9.2 | ฿8.64 |
+343%
|
| Country Average | 8.6 | ฿8.11 |
+316%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
S
|
SEI Medical PCL
SET:SEI
|
331.5m THB | 2.1 | 5.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.5B USD | 17.3 | 24.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD | 13.6 | 38.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.6B USD | 13.6 | 38.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD | 14.8 | 30.6 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.9B AUD | 25.3 | 34 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 8.7 | 11.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY | 13.2 | 17.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 10.8 | 21.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.7 | 8.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 59.9 | 89.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 6.6 |
| Median | 8.6 |
| 70th Percentile | 11.4 |
| Max | 3 584.8 |
Other Multiples
SEI Medical PCL
Glance View
SEI Medical PCL is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-09-24. SEI Medical Public Company Limited is a Thailand-based distributor and service provider of medical equipment and laboratory instruments. The firm is principally engaged in selling scientific and medical equipment, service business, and medical equipment lease contracts. Its segments include Scientific equipment and medical equipment, and Service. Its products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment and laboratory equipment.
